ARCHIVES

HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought

This article is from The Cancer Letter archive.

Vol. 10 No. 30 | July 27, 1984

Download PDF Visit The Full Archive

Related Articles

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

Human Tissue Available Through NCI Network

July 10, 1987

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

AACI, SCO, ACCC Hold Meeting With HCFA On DRG Issue

June 17, 1983

RFOs Available, Contract Awards, Sole Source Negotiations

February 3, 1978

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012